eResearchTechnology Issued a United States Patent For Methods and Systems for Processing Electrocardiograms
June 02 2004 - 9:02AM
PR Newswire (US)
eResearchTechnology Issued a United States Patent For Methods and
Systems for Processing Electrocardiograms Patent Includes More than
50 Claims Associated With eRT's Digital ECG Processing Environment
and EXPeRT(R) System and Methods PHILADELPHIA, June 2
/PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT),
(NASDAQ:ERES), a leading provider of centralized
electrocardiographic collection and interpretation services,
announced today that it has been issued United States Patent No.
6,708,057 (the '057 Patent) for various methods and systems for
processing electrocardio grams. The methods and systems have
particular utility in the collection and interpretation of
electrocardiograms developed during clinical trials. The '057
Patent includes more than 50 claims directed to various features of
eRT's EXPeRT(R) workflow enabled data handling technology, the
first solution in production that was designed explicitly to meet
emerging international regulatory guidance and technical standards.
eRT's EXPeRT(R) system provides integrated technology and processes
across the entire lifecycle of a digital ECG transaction, from
collection, to analysis, management and distribution of results.
Based in Philadelphia, PA, eResearchTechnology, Inc.
(http://www.ert.com/) is a provider of technology and services to
the pharmaceutical, biotechnology and medical device industries on
a global basis. The company is a market leader in providing
centralized core-diagnostic electrocardiographic technology and
services to evaluate cardiac safety in clinical development. The
company is also a leader in providing technology and services to
streamline the clinical trials process by enabling its customers to
automate the collection, analysis, and distribution of clinical
data in all phases of clinical development. Statements included in
this release may constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements involve a number of risks and uncertainties such as
competitive factors and technological development. Further
information on potential factors that could affect the company's
financial results can be found in the company's Reports on Forms
10-K and 10-Q filed with the Securities and Exchange Commission.
DATASOURCE: eResearchTechnology, Inc. CONTACT: Joan Sterlacci of
eResearchTechnology, +1-908-203-6473, or Matt Hayden of Hayden
Communications, +1-858-456-4533, for eResearchTechnology Web site:
http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Tech (MM) News Articles